Advertisement
JOGC

No. 346-Advanced Reproductive Age and Fertility

  • Kimberly E. Liu
    Correspondence
    Corresponding author: Dr. Kimberly E. Liu, Mount Sinai Hospital, Toronto, ON.
    Affiliations
    Toronto, ON
    Search for articles by this author
  • Allison Case
    Affiliations
    Saskatoon, SK
    Search for articles by this author
  • Author Footnotes
    ∗ Reproductive Endocrinology and Infertility committee: Anthony P. Cheung, MD (Co-Chair), Vancouver, BC; Sony Sierra, MD (Co-Chair), Toronto, ON; Belina Carranza-Mamane, MD, Sherbrooke, QC; Catherine Dwyer, RN, Toronto, ON; James Graham, MD, Calgary, AB; Sarah Healey, MD, St. John’s, NL; Robert Hemmings, MD, Montréal, QC; Kimberly Liu, MD, Toronto, ON; Tarek Motan, MD, Edmonton, AB; David Smithson, MD, Ottawa, ON; Tannys D.R. Vause, MD, Ottawa, ON; Benjamin Chee-Man Wong, MD, Calgary, AB. Disclosure statements have been received from all members of the committee.

      Abstract

      Objective

      To improve awareness of the natural age-related decline in female and male fertility with respect to natural fertility and assisted reproductive technologies (ART), provide recommendations for their management, and to review investigations in the assessment of ovarian aging.

      Options

      This guideline reviews options for the assessment of ovarian reserve and fertility treatments using ART with women of advanced reproductive age presenting with infertility.

      Outcomes

      The outcomes measured are the predictive value of ovarian reserve testing and pregnancy rates with natural and assisted fertility.

      Evidence

      Published literature was retrieved through searches of PubMed or Medline, CINAHL, and The Cochrane Library in June 2010, using appropriate key words (“ovarian aging,” “ovarian reserve,” “advanced maternal age,” “advanced paternal age,” and “assisted reproductive technology”). Results were restricted to systematic reviews, randomized controlled trials/controlled clinical trials, and observational studies. There were no date or language restrictions. Searches were updated on a regular basis and incorporated into the guideline to December 2010.

      Values

      The quality of evidence was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care. Recommendations for practice were ranked according to the method described in that report.

      Benefits, Harms, and Costs

      Primary and specialist health care providers and women will be better informed about ovarian aging and the age-related decline in natural fertility and about options for ART.

      Recommendations

      • 1.
        Women in their 20s and 30s should be counselled about the age-related risk of infertility when other reproductive health issues such as sexual health or contraception are addressed as part of their primary well-woman care. Reproductive-age women should be aware that natural fertility and assisted reproductive technology success (except with egg donation) is significantly lower for women in their late 30s and 40s (II-2A).
      • 2.
        Because of the decline in fertility and the increased time to conception that occur after age 35, women >35 should be referred for infertility work-up after 6 months of trying to conceive (III-B).
      • 3.
        Ovarian reserve testing may be considered for women aged ≥35 or for women <35 with risk factors for decreased ovarian reserve, such as a single ovary, previous ovarian surgery, poor response to follicle-stimulating hormone, previous exposure to chemotherapy or radiation, or unexplained infertility (III-B).
      • 4.
        Ovarian reserve testing prior to assisted reproductive technology treatment may be used for counselling but has a poor predictive value for non-pregnancy and should be used to exclude women from treatment only if levels are significantly abnormal (II-2A).
      • 5.
        Pregnancy rates for controlled ovarian hyperstimulation are low for women aged >40. Women >40 should consider in vitro fertilization if they do not conceive within 1 to 2 cycles of controlled ovarian hyperstimulation (II-2B).
      • 6.
        The only effective treatment for ovarian aging is oocyte donation. A woman with decreased ovarian reserve should be offered oocyte donation as an option because pregnancy rates associated with this treatment are significantly higher than those associated with controlled ovarian hyperstimulation or in vitro fertilization with a woman's own eggs (II-2B).
      • 7.
        Women should be informed that the risk of spontaneous pregnancy loss and chromosomal abnormalities increases with age. Women should be counselled about and offered appropriate prenatal screening once pregnancy is established (II-2A).
      • 8.
        Pre-conception counselling regarding the risks of pregnancy with advanced maternal age, promotion of optimal health and weight, and screening for concurrent medical conditions such as hypertension and diabetes should be considered for women aged 40 (III-B).
      • 9.
        Advanced paternal age appears to be associated with an increased risk of spontaneous abortion and increased frequency of some autosomal dominant conditions, autism spectrum disorders, and schizophrenia. Men >40 and their partners should be counselled about these potential risks when they are seeking pregnancy, although the risks remain small (II-2C).

      Key Words

      Abbreviations:

      AFC (antral follicle count), AMH (anti-Müllerian hormone), ART (assisted reproductive technology), COH (controlled ovarian hyperstimulation), FSH (follicle-stimulating hormone), IUI (intrauterine insemination), IVF (in vitro fertilization)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Obstetrics and Gynaecology Canada
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Statistics Canada
        The Daily. Study: Health and development of children of older first-time mothers.
        Statistics Canada, Ottawa2008 (Available at:) (Accessed on April, 26, 2010)
        • Statistics Canada
        The Daily: Births.
        Statistics Canada, Ottawa2008 (Available at:) (Accessed on April 26, 2010)
        • Maher J.
        • Macfarlane A.
        Trends in live births and birthweight by social class, marital status and mother's age, 1976-2000.
        Health Stat Q. 2004; : 34-42
        • Menken J.
        • Trussell J.
        • Larsen U.
        Age and infertility.
        Science. 1986; 233: 1389-1394
        • Leridon H.
        Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment.
        Hum Reprod. 2004; 19: 1548-1553
        • Gilbert W.M.
        • Nesbitt T.S.
        • Danielsen B.
        Childbearing beyond age 40: pregnancy outcome in 24,032 cases.
        Obstet Gynecol. 1999; 93: 9-14
        • Baker T.G.
        A quantitative and cytological study of germ cells in human ovaries.
        Proc R Soc Lond B Biol Sci. 1963; 158: 417-433
        • Richardson S.J.
        • Senikas V.
        • Nelson J.F.
        Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion.
        J Clin Endocrinol Metab. 1987; 65: 1231-1237
        • Faddy M.J.
        • Gosden R.G.
        • Gougeon A.
        • et al.
        Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause.
        Hum Reprod. 1992; 7: 1342-1346
        • Hansen K.R.
        • Knowlton N.S.
        • Thyer A.C.
        • et al.
        A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause.
        Hum Reprod. 2008; 23: 699-708
        • de Bruin J.P.
        • Bovenhuis H.
        • van Noord P.A.
        • et al.
        The role of genetic factors in age at natural menopause.
        Hum Reprod. 2001; 16: 2014-2018
        • Broekmans F.J.
        • Soules M.R.
        • Fauser B.C.
        Ovarian aging: mechanisms and clinical consequences.
        Endocr Rev. 2009; 30: 465-493
        • Nikolaou D.
        • Templeton A.
        Early ovarian ageing: a hypothesis. Detection and clinical relevance.
        Hum Reprod. 2003; 18: 1137-1139
        • Johnson N.P.
        • Bagrie E.M.
        • Coomarasamy A.
        • et al.
        Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International Systematic Collaboration of Ovarian Reserve Evaluation protocol for a systematic review of ovarian reserve test accuracy.
        BJOG. 2006; 113: 1472-1480
        • te Velde E.R.
        • Pearson P.L.
        The variability of female reproductive ageing.
        Hum Reprod Update. 2002; 8: 141-154
        • Stein Z.A.
        A woman's age: childbearing and child rearing.
        Am J Epidemiol. 1985; 121: 327-342
        • Klein N.A.
        • Battaglia D.E.
        • Miller P.B.
        • et al.
        Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
        J Clin Endocrinol Metab. 1996; 81: 1946-1951
        • Klein N.A.
        • Battaglia D.E.
        • Fujimoto V.Y.
        • et al.
        Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women.
        J Clin Endocrinol Metab. 1996; 81: 1038-1045
        • Klein N.A.
        • Harper A.J.
        • Houmard B.S.
        • et al.
        Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development?.
        J Clin Endocrinol Metab. 2002; 87: 5746-5750
        • Pellestor F.
        • Andreo B.
        • Arnal F.
        • et al.
        Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes.
        Hum Genet. 2003; 112: 195-203
        • Volarcik K.
        • Sheean L.
        • Goldfarb J.
        • et al.
        The meiotic competence of in-vitro matured human oocytes is influenced by donor age: evidence that folliculogenesis is compromised in the reproductively aged ovary.
        Hum Reprod. 1998; 13: 154-160
        • Gougeon A.
        • Chainy G.B.
        Morphometric studies of small follicles in ovaries of women at different ages.
        J Reprod Fertil. 1987; 81: 433-442
        • Warburton D.
        Biological aging and the etiology of aneuploidy.
        Cytogenet Genome Res. 2005; 111: 266-272
        • Broekmans F.J.
        • Faddy M.J.
        • Scheffer G.
        • et al.
        Antral follicle counts are related to age at natural fertility loss and age at menopause.
        Menopause. 2004; 11: 607-614
        • Tietze C.
        Fertility after discontinuation of intrauterine and oral contraception.
        Int J Fertil. 1968; 13: 385-389
        • Tietze C.
        Reproductive span and rate of reproduction among Hutterite women.
        Fertil Steril. 1957; 8: 89-97
        • Gunby J.
        • Bissonnette F.
        • Librach C.
        • et al.
        Assisted reproductive technologies (ART) in Canada: 2006 results from the Canadian ART Register.
        Fertil Steril. 2010; 93: 2189-2201
        • Schwartz D.
        • Mayaux M.J.
        Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS.
        N Engl J Med. 1982; 306: 404-406
        • Virro M.R.
        • Shewchuk A.B.
        Pregnancy outcome in 242 conceptions after artificial insemination with donor sperm and effects of maternal age on the prognosis for successful pregnancy.
        Am J Obstet Gynecol. 1984; 148: 518-524
        • Shenfield F.
        • Doyle P.
        • Valentine A.
        • et al.
        Effects of age, gravidity and male infertility status on cumulative conception rates following artificial insemination with cryopreserved donor semen: analysis of 2998 cycles of treatment in one centre over 10 years.
        Hum Reprod. 1993; 8: 60-64
        • van Noord-Zaadstra B.M.
        • Looman C.W.
        • Alsbach H.
        • et al.
        Delaying childbearing: effect of age on fecundity and outcome of pregnancy.
        BMJ. 1991; 302: 1361-1365
      1. Canadian Fertility and Andrology Society. Canadian Assisted Reproductive Technologies Register Plus (CARTR Plus). 2016. Canadian Assisted Reproductive Technologies Registry Plus 2015 Report. Canadian Fertility and Andrology Society. Available at: https://cfas.ca/cartr-annual-reports/. Accessed on October 27, 2016.

        • Centers for Disease Control and Prevention
        2007 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports.
        (Available at:) (Accessed on May 19, 2010)
        • Noci I.
        • Borri P.
        • Chieffi O.
        • et al.
        I. Aging of the human endometrium: a basic morphological and immunohistochemical study.
        Eur J Obstet Gynecol Reprod Biol. 1995; 63: 181-185
        • Woolf S.H.
        • Battista R.N.
        • Anderson G.M.
        • et al.
        Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination.
        J Clin Epidemiol. 1990; 43: 891-905
        • Broekmans F.J.
        • Kwee J.
        • Hendriks D.J.
        • et al.
        A systematic review of tests predicting ovarian reserve and IVF outcome.
        Hum Reprod Update. 2006; 12: 685-718
        • Sherman B.M.
        • West J.H.
        • Korenman S.G.
        The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.
        J Clin Endocrinol Metab. 1976; 42: 629-636
        • Sabatini L.
        • Zosmer A.
        • Hennessy E.M.
        • et al.
        Relevance of basal serum FSH to IVF outcome varies with patient age.
        Reprod Biomed Online. 2008; 17: 10-19
        • Lee T.H.
        • Liu C.H.
        • Huang C.C.
        • et al.
        Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles.
        Reprod Biol Endocrinol. 2009; 7: 100
        • Broekmans F.J.
        • de Z.D.
        • Howles C.M.
        • et al.
        The antral follicle count: practical recommendations for better standardization.
        Fertil Steril. 2010; 94: 1044-1051
        • Hehenkamp W.J.
        • Looman C.W.
        • Themmen A.P.
        • et al.
        Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.
        J Clin Endocrinol Metab. 2006; 91: 4057-4063
        • Sowers M.R.
        • Eyvazzadeh A.D.
        • McConnell D.
        • et al.
        Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.
        J Clin Endocrinol Metab. 2008; 93: 3478-3483
        • Practice Committee of the American Society for Reproductive Medicine
        Aging and infertility in women.
        Fertil Steril. 2006; 86: S248-S252
        • Dovey S.
        • Sneeringer R.M.
        • Penzias A.S.
        Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles.
        Fertil Steril. 2008; 90: 2281-2286
        • Harris I.D.
        • Missmer S.A.
        • Hornstein M.D.
        Poor success of gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination for older women.
        Fertil Steril. 2010; 94: 144-148
        • Tsafrir A.
        • Simon A.
        • Margalioth E.J.
        • et al.
        What should be the first-line treatment for unexplained infertility in women over 40 years of age-ovulation induction and IUI, or IVF?.
        Reprod Biomed Online. 2009; 19: 4334
        • Hourvitz A.
        • Machtinger R.
        • Maman E.
        • et al.
        Assisted reproduction in women over 40 years of age: how old is too old?.
        Reprod Biomed Online. 2009; 19: 599-603
        • Serour G.
        • Mansour R.
        • Serour A.
        • et al.
        Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above.
        Fertil Steril. 2010; 94: 1707-1712
      2. Assisted Human Reproduction Act, S.C. 2004, c. 2, s.7.

      3. Assisted Human Reproduction Act, S.C. 2004, c. 2, s.12.

        • Centers for Disease Control and Prevention
        2005 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports.
        (Available at:) (Accessed on April 23, 2010)
        • Paulson R.J.
        • Thornton M.H.
        • Francis M.M.
        • et al.
        Successful pregnancy in a 63-year-old woman.
        Fertil Steril. 1997; 67: 949-951
        • Jacobsson B.
        • Ladfors L.
        • Milsom I.
        Advanced maternal age and adverse perinatal outcome.
        Obstet Gynecol. 2004; 104: 727-733
        • Joseph K.S.
        • Allen A.C.
        • Dodds L.
        • et al.
        The perinatal effects of delayed childbearing.
        Obstet Gynecol. 2005; 105: 1410-1418
        • Simchen M.J.
        • Yinon Y.
        • Moran O.
        • et al.
        Pregnancy outcome after age 50.
        Obstet Gynecol. 2006; 108: 1084-1088
        • Cleary-Goldman J.
        • Malone F.D.
        • Vidaver J.
        • et al.
        Impact of maternal age on obstetric outcome.
        Obstet Gynecol. 2005; 105: 983-990
        • Schutte J.M.
        • Schuitemaker N.W.
        • Steegers E.A.
        • et al.
        Maternal death after oocyte donation at high maternal age: case report.
        Reprod Health. 2008; 5: 12
        • Smajdor A.
        The ethics of egg donation in the over fifties.
        Menopause Int. 2008; 14: 173-177
        • Havelock J.
        • Liu K.
        • Levitan S.
        • et al.
        Guidelines for Third Party Reproduction. Clinical Practice Guidelines. Canadian Fertility and Andrology Society.
        (Available at:) (Accessed on October 17, 2016)
        • Hook E.B.
        Rates of chromosome abnormalities at different maternal ages.
        Obstet Gynecol. 1981; 58: 282-285
        • McLachlan R.I.
        The endocrine control of spermatogenesis.
        Baillieres Best Pract Res Clin Endocrinol Metab. 2000; 14: 345-362
        • Kidd S.A.
        • Eskenazi B.
        • Wyrobek A.J.
        Effects of male age on semen quality and fertility: a review of the literature.
        Fertil Steril. 2001; 75: 237-248
        • Goldman N.
        • Montgomery M.
        Fecundability and husband's age.
        Soc Biol. 1989; 36: 146-166
        • Ford W.C.
        • North K.
        • Taylor H.
        • et al.
        Increasing paternal age is associated with delayed conception in a large population of fertile couples: evidence for declining fecundity in older men. The ALSPAC Study Team (Avon Longitudinal Study of Pregnancy and Childhood).
        Hum Reprod. 2000; 15: 1703-1708
        • Klonoff-Cohen H.S.
        • Natarajan L.
        The effect of advancing paternal age on pregnancy and live birth rates in couples undergoing in vitro fertilization or gamete intrafallopian transfer.
        Am J Obstet Gynecol. 2004; 191: 507-514
        • de La R.E.
        • de M.J.
        • Thepot F.
        • et al.
        Fathers over 40 and increased failure to conceive: the lessons of in vitro fertilization in France.
        Fertil Steril. 2006; 85: 1420-1424
        • Spandorfer S.D.
        • Avrech O.M.
        • Colombero L.T.
        • et al.
        Effect of parental age on fertilization and pregnancy characteristics in couples treated by intracytoplasmic sperm injection.
        Hum Reprod. 1998; 13: 334-338
        • Aboulghar M.
        • Mansour R.
        • Al-Inany H.
        • et al.
        Paternal age and outcome of intracytoplasmic sperm injection.
        Reprod Biomed Online. 2007; 14: 588-592
        • Gallardo E.
        • Simon C.
        • Levy M.
        • et al.
        Effect of age on sperm fertility potential: oocyte donation as a model.
        Fertil Steril. 1996; 66: 260-264
        • Paulson R.J.
        • Milligan R.C.
        • Sokol R.Z.
        The lack of influence of age on male fertility.
        Am J Obstet Gynecol. 2001; 184: 818-822
        • Dain L.
        • Auslander R.
        • Dirnfeld M.
        The effect of paternal age on assisted reproduction outcome.
        Fertil Steril. 2011; 95: 1-8
        • Luna M.
        • Finkler E.
        • Barritt J.
        • et al.
        Paternal age and assisted reproductive technology outcome in ovum recipients.
        Fertil Steril. 2009; 92: 1772-1775
        • Frattarelli J.L.
        • Miller K.A.
        • Miller B.T.
        • et al.
        Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles.
        Fertil Steril. 2008; 90: 97-103
        • Kleinhaus K.
        • Perrin M.
        • Friedlander Y.
        • et al.
        Paternal age and spontaneous abortion.
        Obstet Gynecol. 2006; 108: 369-377
        • Maconochie N.
        • Doyle P.
        • Prior S.
        • et al.
        Risk factors for first trimester miscarriage—results from a UK-population-based case-control study.
        BJOG. 2007; 114: 170-186
        • Erickson J.D.
        Paternal age and Down syndrome.
        Am J Hum Genet. 1979; 31: 489-497
        • Erickson J.D.
        • Bjerkedal T.O.
        Down syndrome associated with father's age in Norway.
        J Med Genet. 1981; 18: 22-28
        • Hook E.B.
        • Cross P.K.
        Paternal age and Down's syndrome genotypes diagnosed prenatally: no association in New York state data.
        Hum Genet. 1982; 62: 167-174
        • Stene J.
        • Fischer G.
        • Stene E.
        • et al.
        Paternal age effect in Down's syndrome.
        Ann Hum Genet. 1977; 40: 299-306
        • Toriello H.V.
        • Meck J.M.
        Statement on guidance for genetic counseling in advanced paternal age.
        Genet Med. 2008; 10: 457-460
        • Tough S.C.
        • Faber A.J.
        • Svenson L.W.
        • et al.
        Is paternal age associated with an increased risk of low birthweight, preterm delivery, and multiple birth?.
        Can J Public Health. 2003; 94: 88-92
        • Basso O.
        • Wilcox A.J.
        Paternal age and delivery before 32 weeks.
        Epidemiology. 2006; 17: 475-478
        • Astolfi P.
        • De Pasquale A.
        • Zonta L.A.
        Paternal age and preterm birth in Italy, 1990 to 1998.
        Epidemiology. 2006; 17: 218-221
        • Orioli I.M.
        • Castilla E.E.
        • Scarano G.
        • et al.
        Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta.
        Am J Med Genet. 1995; 59: 209-217
        • North K.
        Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic.
        J Child Neurol. 1993; 8: 395-402
        • Bunin G.R.
        • Needle M.
        • Riccardi V.M.
        Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues.
        Genet Epidemiol. 1997; 14: 507-516
        • Jadayel D.
        • Fain P.
        • Upadhyaya M.
        • et al.
        Paternal origin of new mutations in von Recklinghausen neurofibromatosis.
        Nature. 1990; 343: 558-559
        • Riccardi V.M.
        • Dobson C.E.
        • Chakraborty R.
        • et al.
        The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations.
        Am J Med Genet. 1984; 18: 169-176
        • Carothers A.D.
        • McAllion S.J.
        • Paterson C.R.
        Risk of dominant mutation in older fathers: evidence from osteogenesis imperfecta.
        J Med Genet. 1986; 23: 227-230
        • Lauritsen M.B.
        • Pedersen C.B.
        • Mortensen P.B.
        Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study.
        J Child Psychol Psychiatry. 2005; 46: 963-971
        • Reichenberg A.
        • Gross R.
        • Weiser M.
        • et al.
        Advancing paternal age and autism.
        Arch Gen Psychiatry. 2006; 63: 1026-1032
        • Croen L.A.
        • Najjar D.V.
        • Fireman B.
        • et al.
        Maternal and paternal age and risk of autism spectrum disorders.
        Arch Pediatr Adolesc Med. 2007; 161: 334-340
        • Malaspina D.
        • Harlap S.
        • Fennig S.
        • et al.
        Advancing paternal age and the risk of schizophrenia.
        Arch Gen Psychiatry. 2001; 58: 361-367
        • Byrne M.
        • Agerbo E.
        • Ewald H.
        • et al.
        Parental age and risk of schizophrenia: a case-control study.
        Arch Gen Psychiatry. 2003; 60: 673-678
        • Tsuchiya K.J.
        • Takagai S.
        • Kawai M.
        • et al.
        Advanced paternal age associated with an elevated risk for schizophrenia in offspring in a Japanese population.
        Schizophr Res. 2005; 76: 337-342
        • Zammit S.
        • Allebeck P.
        • Dalman C.
        • et al.
        Paternal age and risk for schizophrenia.
        Br J Psychiatry. 2003; 183: 405-408